3 studies found for:    Open Studies | "Aspergillosis, Allergic Bronchopulmonary"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
Intervention:
2 Recruiting A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole;   Drug: Glucocorticoids
3 Recruiting Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Condition: Allergic Bronchopulmonary Aspergillosis
Intervention: Drug: Liposomal amphotericin B (Ambisome®)

Indicates status has not been verified in more than two years